Eyeworld

EW FEATURE 56 Products that could change how you practice • September 2018 vations now confirm that there is a lower utilization of over-the-count- er tears once TrueTear therapy is established. Furthermore, this is the first truly patient-controlled dry eye therapy, where the patient chooses dose, frequency, and duration based on their own response and their own daily variability. With such ver- satility, economy, and control, there may be tremendous cost savings for patients," he explained. Pearls to explain TrueTear Prescribing a device that patients have to put in their nose instead of using eye drops takes some extra chair time. There are several pearls to make patient education easier. "Once you get over the novelty of putting something in the nose, it makes a lot of sense," Dr. Sheppard said. 1. Use the available infor- mation from the manufacturer. On the TrueTear website, there is a patient guide and a video, both of which physicians said are helpful and useful to share with patients. "[The video] saves substantial chair time as well as being an excellent introduction to the device and directions on its use," Dr. Faulkner said. 2. Have a device available to use in your office. Patients can spend time with someone on your staff who can demonstrate it and let patients try it out, Dr. Pflugfelder said. This helps to eliminate some of the hesitation about TrueTear and gives patients a chance to see if it works well for them. "The majority of patients are OK with it if it gets their eyes moist," Dr. Pflugfelder said. Dr. Faulkner's study found that intranasal placement did not seem to be a significant negative factor in selecting whether to use the device or not. 3. Discuss cost savings. If you think the device would help many of your patients, have someone who will help patients analyze the costs of the device versus the cost of other dry eye treatments and medications they use. This can help them see if there is a long-term cost savings, Dr. Sheppard said. 4. Place device use in context. Dr. Sheppard and his staff still dis- cuss other dry eye lifestyle and diet modifications, including the con- sumption of essential fatty acids and environmental optimization. EW References 1. Instructions for use. www.truetear.com 2. Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neuro- stimulator. May 16, 2016. www.allergan.com/ news/news/thomson-reuters/allergan-an- nounces-positive-pivotal-trial-results. 3. Gumus K, et al. Randomized controlled crossover trial comparing the impact of sham or intranasal tear neurostimulation on conjunctival goblet cell degranulation. Am J Ophthalmol. 2017;177:159–168. Editors' note: Dr. Lewis has financial interests with Aerie Pharmaceuticals (Irvine, California), Allergan, and Alcon (Fort Worth, Texas). Dr. Pflugfelder has financial interests with Allergan and Bausch + Lomb (Bridgewater, New Jer- sey). Dr. Sheppard has financial inter- ests with Alcon, Allergan, and Bausch + Lomb. Dr. Faulkner has no financial interests related to his comments. Contact information Faulkner: wfaulkner@cincinnatieye.com Lewis: rlewiseyemd@yahoo.com Pflugfelder: stevenp@bcm.edu Sheppard: docshep@hotmail.com At Dr. Sheppard's office, some patients do not want to buy any- thing that is not covered by insur- ance. Nevertheless, he still has found an opportunity for many with Tru- eTear. "I think with education and knowledge, neurostimulation can solve a number of clinical and com- pliance problems, especially realiz- ing that a large number of promised medications and lid procedures will actually never be employed. Obser- Neurostimulation continued from page 54 Experience the Freedom Brought Through Relief. True Dry Eye Solutions Punctum Plugs available: short term, medium term, and long term Call: (844) 820-8940 Email: Oasis@oasismedical.com | Register: www.oasismedical.com From the company that brought your practice SOFT PLUG ® , FORM FIT ® & OASIS ® , Oasis Tears ® and Oasis names & logos are registered trademarks of OASIS ® Medical, Inc. 514 S Vermont Ave, Glendora, CA 91741. LIT-DE-Ad-AAOEWPre2018 Rev.0 08.2018 Up to Long term Up to Up to 5 3 6 months months days SOFT PLUG ® Collagen SOFT PLUG ® Extended Duration SOFT PLUG ® Extended Duration 180 FORM FIT ® Hydrogel SOFT PLUG ® Silicone SOFT PLUG Extended Duration 180 SOFT PLUG Extended Duration Visit Us At AAO Chicago, IL Booth #2600

• Blank Page
• Blank Page (1)